Pclg ATC indicts suspects in Intezar murder case
PESHAWAR:To improve and strengthen the municipal infrastructure and
nike af services, the provincial government has decided to launch a pilot project in five major cities of the province.This was disclosed during a meeting of the provincial Local Government Department on Tuesday. Khyber-Pakhtunkhwa (K-P) Chief Minister Mahmood Khan presided over the meeting.The meeting was briefed that the project is being launched to improve citizens access to quality urban services through enhanced municipal infrastructure and to further strengthen the insti
air force alte tutional capacities of municipal setups.Titled Citizens Improvement Project (CIP), the project will be first implemented in the Peshawar, Kohat, Abbottabad, Mardan and Swat districts.The chief minister was informed that under CIP, schemes for drinking water, solid waste management, sewerage treatment plants, construction of parks and recreational spots, development of green areas will be launched in the
new balance se cities.The project will receive financial assista Gzpw Senate body finalises budget proposals
NEW YORK:Investors are diversifying bets in the healthcare sector, as they rush to develop treatments for Covid-19 has driven up prices for some pharmaceutical stocks.A record 48% of fund managers are overweight health
air max 96 care stocks, a BofA survey showed and the S amp P 500 healthcare sector is up nearly 34% since its March low.Hopes for treatment have also sparked outsize rallies in the shares of companies such as Moderna and Inovio Pharmaceuticals, up 253% and 327% since the start of the year, respectively, as of Friday s close.In recent weeks, news of potential treatments or vaccines to fight the pandemic have occasionally fuelled swings in broader markets.Yet some fund managers believe lasting
nike af1 white profits may be elusive for vaccine-makers, leading them to seek corners of the healthcare sector that could see longer-term benefits from the figh
nike dunk t against coronavirus.Large pharmaceutical companies such as Johnson amp Johnson and GlaxoSmithKline have said they plan to make any successful vacc
